Biblio Discovery — Demo Discovery Service

50 hasil untuk "Modlin, Irvin"

Menampilkan 1–20 · 0,53 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Foreword

    Modlin, Irvin M.

    Yale J Biol Med · 1998 · Inggris · PubMed Central

  2. Artikel Jurnal Teks lengkap

    Foreword

    Modlin, Irvin M.

    Yale J Biol Med · 1998 · Inggris · PubMed Central

  3. Artikel Jurnal Teks lengkap

    Foreword

    Modlin, Irvin M.

    Yale J Biol Med · 1996 · Inggris · PubMed Central

  4. Artikel Jurnal Teks lengkap

    Foreword

    Modlin, Irvin M.

    Yale J Biol Med · 1997 · Inggris · PubMed Central

  5. Artikel Jurnal Teks lengkap

    Foreword

    Modlin, Irvin M.

    Yale J Biol Med · 1997 · Inggris · PubMed Central

  6. Artikel Jurnal Teks lengkap

    Foreword

    Modlin, Irvin M.

    Yale J Biol Med · 1992 · Inggris · PubMed Central

  7. Artikel Jurnal Teks lengkap

    Discussion: Enterochromaffin-Like Cell Pathobiology

    Modlin, Irvin M.

    Yale J Biol Med · 1992 · Inggris · PubMed Central

  8. Artikel Jurnal Teks lengkap

    The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood

    Modlin, Irvin M.; Drozdov, Ignat; Kidd, Mark

    PLoS One · 2013 · Inggris · PubMed Central

    Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are increasing in both incidence and prevalence. A delay in correct diagnosis is common for these lesions. This reflects the absence of specific blood biomarkers to detect NENs. Measurement of the neuroendocrine secretory peptide…

  9. Artikel Jurnal Teks lengkap

    Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors

    Kidd, Mark; Modlin, Irvin M; Drozdov, Ignat

    BMC Genomics · 2014 · Inggris · PubMed Central

    BACKGROUND: Tumor transcriptomes contain information of critical value to understanding the different capacities of a cell at both a physiological and pathological level. In terms of clinical relevance, they provide information regarding the cellular “toolbox” e.g., pathways associated with…

  10. Artikel Jurnal Teks lengkap

    New Pharmacologic Therapies for Gastroenteropancreatic Neuroendocrine Tumors

    Lawrence, Ben; Gustafsson, Bjorn I.; Kidd, Mark dkk.

    Gastroenterol Clin North Am · 2010 · Inggris · PubMed Central

    Successful treatment of unresectable and metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) requires the thoughtful choice of systemic therapy as a component of a multidisciplinary therapeutic approach. The role of somatostatin analogs is established in symptom relief, but there is…

  11. Artikel Jurnal Teks lengkap

    Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology

    Kidd, Mark; Modlin, Irvin M.; Bodei, Lisa dkk.

    Cell Mol Gastroenterol Hepatol · 2015 · Inggris · PubMed Central

    Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN), considered a heterogeneous neoplasia, exhibit ill-defined pathobiology and protean symptomatology and are ubiquitous in location. They are difficult to diagnose, challenging to manage, and outcome depends on cell type, secretory product…

  12. Artikel Jurnal Teks lengkap

    Blood transcript analysis and metastatic recurrent small bowel carcinoid management

    Modlin, Irvin M; Drozdov, Ignat; Bodei, Lisa dkk.

    BMC Cancer · 2014 · Inggris · PubMed Central

    BACKGROUND: Detection of neuroendocrine tumor (NET) disease progression is a key issue in determining management. Currently, assessment is by imaging (MRI/CT and Octreoscan®) and plasma Chromogranin A (CgA) measurement. CASE PRESENTATION: We report use of a NET-specific multigene PCR-derived blood…

  13. Artikel Jurnal Teks lengkap

    The NETest liquid biopsy identifies paragangliomas and pheochromocytomas with ~100% accuracy

    Pacak, Karel; Kidd, Mark; Meuter, L. dkk.

    Endocr Relat Cancer · 2021 · Inggris · PubMed Central

    Pheochromocytomas and paragangliomas (PHEOs/PGLs) represent diagnostically challenging and complex neuroendocrine tumors. Current biomarker tests for PHEOs/PGLs are technically complex or limited. We assessed the diagnostic utility of the NETest in patients with PHEOs/PGLs (n=81), including 10…

  14. Artikel Jurnal Teks lengkap

    The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumors

    Bodei, Lisa; Ćwikla, Jarosław B.; Kidd, Mark dkk.

    J Thorac Dis · 2017 · Inggris · PubMed Central

    Bronchopulmonary (BP) neuroendocrine tumors (NETs) comprise a spectrum of tumors that develop from respiratory neuroendocrine cells and represent ~20% of all lung neoplasia and ~30% of all NETs. The only curative treatment is surgical resection. For well-differentiated forms (typical and atypical…

  15. Artikel Jurnal Teks lengkap

    Cyclin D1 Antisense Oligonucleotide Inhibits Cell Growth Stimulated by Epidermal Growth Factor and Induces Apoptosis of Gastric Cancer Cells

    Saikawa, Yoshiro; Kubota, Tetsuro; Otani, Yoshihide dkk.

    Jpn J Cancer Res · 2001 · Inggris · PubMed Central

    The cyclin Dl protein is one of the cell cycle regulators required for cell cycle progression through Gl phase to S phase. The cyclin Dl‐cyclin‐dependent kinase (CDK) system is thought to control the cell cycle through mediating extracellular signals from mitogens, such as epidermal growth factor…

  16. Artikel Jurnal Teks lengkap

    A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors

    Modlin, Irvin M; Aslanian, Harry; Bodei, Lisa dkk.

    Endocr Connect · 2014 · Inggris · PubMed Central

    A critical requirement in neuroendocrine tumor (NET) management is a blood biomarker test that is sensitive, specific and reproducible. We evaluated a PCR-based 51-transcript signature to detect tumors, compared it with chromogranin A (CgA) and examined the confounding effect of proton pump…

  17. Artikel Jurnal Teks lengkap

    Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation

    Giovinazzo, Francesco; Schimmack, Simon; Svejda, Bernhard dkk.

    PLoS One · 2013 · Inggris · PubMed Central

    INTRODUCTION: Chromogranin A is a neuroendocrine secretory product and its loss is a feature of malignant NEN de-differentiation. We hypothesized that chromogranin A fragments were differentially expressed during NEN metastasis and played a role in the regulation of NEN proliferation. METHODS…

  18. Artikel Jurnal Teks lengkap

    Priorities for Improving the Management of Gastroenteropancreatic Neuroendocrine Tumors

    Modlin, Irvin M.; Moss, Steven F.; Chung, Daniel C. dkk.

    J Natl Cancer Inst · 2008 · Inggris · PubMed Central

    A National Cancer Institute summit meeting on gastroenteropancreatic neuroendocrine and carcinoid tumors was held in September 2007 to present the currently accepted standards of care for patients with these tumors and to identify areas requiring investigation and development. These tumors are…

  19. Artikel Jurnal Teks lengkap

    Q RT-PCR Detection of Chromogranin A

    Kidd, Mark; Modlin, Irvin M.; Mane, Shrikant M. dkk.

    Ann Surg · 2006 · Inggris · PubMed Central

    OBJECTIVE: Message and protein expression of CgA was examined to evaluate the sensitivity of a PCR-based approach in the detection of covert neuroendocrine (NE) tissue. SUMMARY BACKGROUND DATA: Immunohistochemical (IHC) measurement of chromogranin A (CgA) discriminates gastrointestinal (GI)…